Skip to Main Content
Q+A

Christopher Whitlow on the Research and Practice—and Creativity—of Radiology

6 Minute Read

Christopher Whitlow, MD, PhD, joined Yale School of Medicine on Oct. 20 as the new chair of the Department of Radiology and Biomedical Imaging and assistant dean for translational research. He also serves as chief of radiology at Yale New Haven Hospital and radiologist-in-chief across Yale New Haven Health System.

As a neuroradiologist and data-scientist, Whitlow’s work spans advanced magnetic resonance imaging (MRI), positron emission tomography (PET), data science, translational neuroscience, AI-driven imaging analytics, and image-guided clinical care. His clinical practice and research are closely intertwined: Insights from patient care drive his use of imaging and computational data techniques to better understand disease development.

Whitlow previously served as chair of radiology at Advocate Health/Wake Forest University School of Medicine, overseeing one of the nation’s largest multi-state imaging networks. He notes that he was not actively seeking a new role.

“But it quickly became clear that Yale School of Medicine and Yale New Haven Health System are truly special with remarkable collegiality, some of the brightest minds in the field, and research imaging infrastructure that is among the most advanced and comprehensive,” he says.

“I remember thinking, ‘They have the expertise, they have the tools, and groundbreaking work is being done at Yale.’ Ultimately, the opportunity to serve the world-class scientists and physicians at Yale, as well as the extraordinary opportunities for growth within the health system created the gravity that ultimately drew me in.”

We sat down with Whitlow to talk about his research, his goals for Yale Radiology, and how creativity, connection, and curiosity sit at the heart of his work. This interview has been condensed and edited for clarity.

How would you describe your research interests?

Christopher Whitlow, MD, PhD: My research sits at the intersection of imaging, data science, neuroscience, and translational innovation. I use advanced MRI, PET, and computational methods, including artificial intelligence and high-throughput analytic pipelines, to understand the pathophysiology of diseases, particularly as they affect the brain. My work ranges from early neurodevelopment through later adulthood, and focuses on conditions such as traumatic brain injury, Alzheimer's disease, neurooncology, preterm birth, adolescent exposure to nicotine, as well as the impact of metabolic and vascular factors on neurodegeneration.

In my Radiology Informatics and Image Processing Lab (RIIPL), we integrate multi-site datasets, computational modeling, AI, and translational neuroscience to deepen our biological understanding and ultimately improve patient care. Imaging is not just a window into the body, it is a quantitative, multi-dimensional measurement tool. I’m interested in how we translate that information into clinical decision making that truly changes outcomes.

How does this connect with your clinical specialty?

Whitlow: Perfectly. As a neuroradiologist, my clinical practice centers on imaging of brain, head, neck, and spine, as well as minimally invasive image-guided procedures. The clinical problems I encounter every day—evaluating patients with cognitive disorders and brain injuries and characterizing brain tumors—directly inform the scientific questions my research aims to answer. That reciprocal relationship is essential. For me, scientific innovation must be grounded in real patient needs, and clinical care advances most rapidly when informed by rigorous science.

What got you interested in this field?

Whitlow: I actually started college as an art major. I was a painter deeply immersed in the creative process. But while working to pay my way through college, splitting time between a neuroscience lab and weekend patient-care roles, I realized how much I enjoyed understanding how the brain works and connecting with patients.

What surprised me was discovering how creative medicine is. Research is especially creative, and (in my opinion) generating hypotheses is not unlike conceptualizing a painting. Clinical practice is also creative: Many situations don’t fit neatly in a textbook, and you must reason, improvise, and problem solve in real time.

Radiology, in particular, blends science and art. You interpret images, integrate information, and tell a story about what is happening inside the human body. It’s a different kind of canvas, but one that uses similar creative muscles.

What are your goals as chair?

Whitlow: I think of my job through the tripartite lens of clinical care, research, and education. Clinically, my immediate priority is to support and elevate an already extraordinary department. Yale Radiology has a tremendous foundation of excellence, and we want to expand high-impact care across the region and beyond. My experience serving as a leader in one of the nation’s largest imaging enterprises has shown me the power of coordinated systems, data-informed decision making, and culture-building at scale.

In research, we want Yale Radiology to further elevate its already international eminence in imaging science, quantitative biomarkers, AI, and translational imaging via continued physician and scientist collaboration with clinical departments and other centers and institutes at Yale, as well as other institutions and organizations across the globe. We would like Yale Radiology to remain a critical hub for interdisciplinary discovery.

In education, we have a profound responsibility to train the next generation of radiologists and imaging scientists. Our success will be defined by how effectively we mentor, empower, and elevate tomorrow’s leaders. That includes giving trainees not only the standards of today’s practice but also the tools to reinvent the standards of tomorrow.

And finally, I hope to serve as a bridge builder—strengthening relationships across Yale School of Medicine and Yale New Haven Health, and weaving radiology more tightly into the scientific and clinical fabric of our entire health ecosystem.

These themes of support, innovation, education, and connection are core to my leadership philosophy and the values I emphasize in every team I’ve led.

Biomedical imaging touches every subspecialty of medicine. Do those connections transfer to the research side as well?

Whitlow: Imaging sits at the center of modern medicine. For example, as a neuroradiologist, I work closely with colleagues in neurology, neurosurgery, psychiatry, orthopedics, internal medicine, and many others. These “team-medicine” partnerships shape the scientific questions we pursue in biomedical imaging.

Radiology also brings something unique to interdisciplinary science: expertise in how to acquire, analyze, quantify, and interpret imaging and physiologic data. Our faculty are experts in imaging diagnostic interpretation, physics, biomarker development, quantitative image analysis, and AI. We want to make that expertise widely available to serve as a resource for any investigator whose work touches imaging.

Yale is ideally positioned for this. The collaboration potential here is extraordinary, and I’m excited to help build those bridges.

You’re coming to us from Winston-Salem, N.C. How are you liking the transition to the Northeast?

Whitlow: We’re loving it. Connecticut is such a charming state. The proximity to New York City, Boston, and a vibrant arts and music culture in Connecticut has been a wonderful part of the transition. As a former art major, having world-class museums so close is deeply fulfilling. My partner is a health care marketing executive by day, but also a classically trained soprano and opera singer. She has loved being near the rich performing arts scene.

Article outro

Author

Mallory Locklear, PhD
Managing Editor—Science, Research, and Education

Tags

Media Contact

For media inquiries, please contact us.

Explore More

Featured in this article